touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchHAEMATOLOGY

    touchMDT for touchHAEMATOLOGY

    Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.

    The multidisciplinary team

    • HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
  • Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

    • This touchPODCAST is for healthcare professionals in the USA only.

    This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

    13 min
  • Recognizing and managing HLH in the critical care setting Best practice for the multidisciplinary team - Part 1 touchIMMUNOLOGY

    touchMDT for touchIMMUNOLOGY

    Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.

    The multidisciplinary team

    • HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
  • Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

    • This touchPODCAST is for healthcare professionals in the USA only.

    This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

    14 min
  • Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchIMMUNOLOGY

    touchMDT for touchIMMUNOLOGY

    Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.

    The multidisciplinary team

    • HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
  • Pathologist: Dr Eric Gars, Gainesville, FL, USA

    • This touchPODCAST is for healthcare professionals in the USA only.

    This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

    12 min
  • Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchIMMUNOLOGY

    touchMDT for touchIMMUNOLOGY

    Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. 

    The multidisciplinary team

    • HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
  • Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
  • Critical care pharmacist: Prof. Rob MacLaren, Denver, CO

    • This touchPODCAST is for healthcare professionals in the USA only.

    This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

    14 min
  • Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchIMMUNOLOGY

    touchMDT for touchIMMUNOLOGY

    Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.

    The multidisciplinary team

    • HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
  • Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

    • This touchPODCAST is for healthcare professionals in the USA only.

    This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

    13 min
  • Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis

    touchIN CONVERSATION for touchNEUROLOGY

    Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the importance of early recognition and diagnosis.

    This touchPODCAST is for healthcare professionals outside of the UK only.

    This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).

    For further information visit our website: https://touchneurology.com/education/mdt-perspectives-on-management-of-agitation-in-alzheimers-dementia/in-conversation-lets-talk-about-AAD/

    44 min
  • Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

    touchPANEL DISCUSSION for touchONCOLOGY

    Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

    The experts

    • Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
  • Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
  • Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

    • This touchPODCAST is for HCPs outside of the UK only. 

    This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

    For further information visit: 

    https://touchoncologyime.org/mdt-insights-systemic-mastocytosis

    52 min
  • Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

    touchPANEL DISCUSSION for touchHAEMATOLOGY 

    Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

    The experts

    • Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
  • Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
  • Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

    • This touchPODCAST is for HCPs outside of the UK only. 

    This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

    For further information visit: 

    https://touchhaematologyime.org/mdt-insights-systemic-mastocytosis

    52 min
  • Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

    touchPANEL DISCUSSION for touchDERMATOLOGY 

    Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

    The experts

    • Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
  • Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
  • Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

    • This touchPODCAST is for HCPs outside of the UK only. 

    This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

    For further information visit: 

    https://touchdermaime.org/mdt-insights-systemic-mastocytosis

    52 min
  • Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

    touchPANEL DISCUSSION for touchIMMUNOLOGY

    Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

    The experts

    • Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
  • Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
  • Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

    • This touchPODCAST is for HCPs outside of the UK only. 

    This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

    For further information visit: 

    https://touchimmunologyime.org/mdt-insights-systemic-mastocytosis

    52 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.